Ileus
Drug research and approvals for ileus: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 17, 2026, 28 studies of ileus are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 28
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 28 recruiting on ClinicalTrials.gov ↗- The Food Network EffectNCT07618559 · Not applicable · Casey Morehouse, DO · starts Jul 1, 2026
- Oral Lactulose for Gastrointestinal Recovery After Complex AppendectomyNCT07589465 · Not applicable · Nanchong Central Hospital · starts Jun 21, 2026
- Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in…NCT07651722 · Not applicable · Tianjin First Central Hospital · starts Jun 16, 2026
- The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE TrialNCT07574515 · Not applicable · University Hospital, Linkoeping · starts May 27, 2026
- Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean SectionNCT07440667 · Not applicable · Nigde Omer Halisdemir University · starts Mar 4, 2026
- Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal SurgeryNCT07412223 · Phase 4 · Xiangya Hospital of Central South University · starts Feb 24, 2026
- Role of ACTG2 Variants in Smooth Muscle Determination and Function in Pediatric Intestinal Pseudo-obstruction.NCT06687564 · Not applicable · University Hospital, Grenoble · starts Feb 4, 2026
- The Value of Bowel Sounds in Evaluating Postoperative Intestinal Function Recovery in Colorectal Cancer PatientsNCT07705139 · Not reported · Zhongnan Hospital · starts Feb 1, 2026
- Impact of Chewing Gum on Postoperative Gut Motility in Gastrointestinal Surgery PatientsNCT07425249 · Not applicable · Khyber Medical University Peshawar · starts Jan 1, 2026
- At-Home Bowel StimulationNCT07574437 · Not reported · The Cleveland Clinic · starts Oct 28, 2025
Drug Pipeline
10 in phase 3, 9 in phase 2, 2 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition- Alvimopan
- Phase 3 Mu opioid receptor antagonist
- Tranexamic acid
- Phase 3 Plasminogen inhibitor
- Methylnaltrexone
- Phase 3 Mu opioid receptor antagonist
- Ulimorelin
- Phase 3 Ghrelin receptor agonist
- Lidocaine
- Phase 3 Sodium channel alpha subunit blocker
- Dextrose
- Phase 3
- Bupivacaine
- Phase 3 Sodium channel protein type IV alpha subunit blocker
- Hydromorphone
- Phase 3 Mu opioid receptor agonist
- Naloxegol
- Phase 3 Mu opioid receptor antagonist
- Mosapride
- Phase 3 Serotonin 3 (5-HT3) receptor antagonist
- TU-100
- Phase 2
- Pyridostigmine
- Phase 2 Acetylcholinesterase inhibitor
- Caffeine
- Phase 2 Adenosine receptor antagonist
- Prucalopride
- Phase 2 Serotonin 4 (5-HT4) receptor agonist
- Asimadoline
- Phase 2 Kappa opioid receptor agonist
- Diatrizoic acid
- Phase 2 Diagnostic agent
- Carbon monoxide
- Phase 2
- Water
- Phase 2
- Ipamorelin
- Phase 2
- Dexamethasone
- Phase 1 Glucocorticoid receptor agonist
- Oxygen
- Phase 1 Essential for cellular homeostasis
How Its Trials Ended
119 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 34 whose ending is known, 41% met their primary endpoint, 12% missed it and 47% stopped early.
- Completed, result not reported4941%
- Status unknown2319%
- Met its primary endpoint1412%
- Ongoing1311%
- Stopped: other or unclear87%
- Missed its primary endpoint43%
- Stopped: enrollment or feasibility43%
- Stopped: sponsor or business decision33%
- Stopped: lack of efficacy11%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA